Nabi Biopharmaceuticals
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals focuses on the development and commercialization of products that prevent and treat infectious and autoimmune diseases.
Website URL : http://www.nabi.com
Stock Ticker : NABI
Nabi Biopharmaceuticals focuses on the development and commercialization of products that prevent and treat infectious and autoimmune diseases.
Website URL : http://www.nabi.com
Stock Ticker : NABI
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX(R) (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company is headquartered in Rockville, Maryland.
© Copyright 2012. HealthcareFirms.com | Heathcare Company Web Directory - Theme by DirectoryPress 2.10 - Developed By Mark Fail Site Map | Terms & Conditions | Privacy Policy